Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients

BackgroundThe prevalence of invasive pulmonary aspergillosis (IPA) among patients with chronic obstructive pulmonary disease (COPD) is steadily increasing, leading to high mortality. Although early diagnosis can significantly reduce mortality, the efficacy of current diagnostic methods is limited. C...

Full description

Bibliographic Details
Main Authors: Zhiwei Long, Xiaotong Li, Zhengtu Li, Jieying Hu, Ye Qiu, Shaoqiang Li, Yangqing Zhan, Feng Ye, Yan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1294971/full
_version_ 1827295848046788608
author Zhiwei Long
Xiaotong Li
Zhengtu Li
Jieying Hu
Ye Qiu
Shaoqiang Li
Yangqing Zhan
Feng Ye
Yan Wang
author_facet Zhiwei Long
Xiaotong Li
Zhengtu Li
Jieying Hu
Ye Qiu
Shaoqiang Li
Yangqing Zhan
Feng Ye
Yan Wang
author_sort Zhiwei Long
collection DOAJ
description BackgroundThe prevalence of invasive pulmonary aspergillosis (IPA) among patients with chronic obstructive pulmonary disease (COPD) is steadily increasing, leading to high mortality. Although early diagnosis can significantly reduce mortality, the efficacy of current diagnostic methods is limited. Consequently, there is a need for novel approaches for early IPA detection.MethodsThis retrospective study involved 383 hospitalized COPD patients with GOLD stages III and IV. The IPA group (67 patients) and non-IPA group (316 patients) were identified at the First Affiliated Hospital of Guangzhou Medical University between January 2016 and February 2022. We analyzed common serological indicators in our hospital to identify predictive indicators for the early diagnosis of IPA in COPD patients.ResultsThe sensitivity and specificity of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), lactate dehydrogenase (LDH), and ceruloplasmin (CER) for diagnosing IPA in COPD patients were as follows: CRP (91.2%, 57.7%), ESR (77.5%, 73.0%), PCT (60.5%, 71.4%), LDH (50.0%, 88.8%), and CER (60.7%, 74.3%). Combinations of biomarkers, such as CRP-ESR, CRP-LDH, ESR-LDH, ESR-CER, and LDH-CER, showed promising diagnostic potential, with larger area under the curve (AUC) values for IPA diagnosis in COPD patients. However, no statistically significant difference was observed between the diagnostic efficacy of single biomarkers and combined biomarkers. Notably, compared to those in the unassisted ventilation group, the patients in the assisted ventilation group (including noninvasive ventilation and tracheal intubation/incision-assisted ventilation group) exhibited significantly greater PCT and LDH levels, while the CER significantly decreased (p=0.021). There were no significant differences in biomarker levels between the ICU group and the non-ICU group. CRP (p<0.01), ESR (p=0.028), PCT (p<0.01), and CER (p<0.01) were positively correlated with hospitalization duration, whereas LDH was not correlated with hospitalization duration.ConclusionOur study highlights the diagnostic potential of CRP, ESR, PCT, LDH, and CER for IPA in COPD patients. CRP and LDH can also initially predict the need for assisted ventilation, while CRP can initially estimate the length of hospitalization. This study represents the first report of the potential of CER for diagnosing IPA, suggesting its significance for further research.
first_indexed 2024-04-24T14:27:18Z
format Article
id doaj.art-d057c1d7fff14fa4956ca88013a76522
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-24T14:27:18Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-d057c1d7fff14fa4956ca88013a765222024-04-03T04:32:42ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-04-011410.3389/fcimb.2024.12949711294971Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patientsZhiwei LongXiaotong LiZhengtu LiJieying HuYe QiuShaoqiang LiYangqing ZhanFeng YeYan WangBackgroundThe prevalence of invasive pulmonary aspergillosis (IPA) among patients with chronic obstructive pulmonary disease (COPD) is steadily increasing, leading to high mortality. Although early diagnosis can significantly reduce mortality, the efficacy of current diagnostic methods is limited. Consequently, there is a need for novel approaches for early IPA detection.MethodsThis retrospective study involved 383 hospitalized COPD patients with GOLD stages III and IV. The IPA group (67 patients) and non-IPA group (316 patients) were identified at the First Affiliated Hospital of Guangzhou Medical University between January 2016 and February 2022. We analyzed common serological indicators in our hospital to identify predictive indicators for the early diagnosis of IPA in COPD patients.ResultsThe sensitivity and specificity of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), lactate dehydrogenase (LDH), and ceruloplasmin (CER) for diagnosing IPA in COPD patients were as follows: CRP (91.2%, 57.7%), ESR (77.5%, 73.0%), PCT (60.5%, 71.4%), LDH (50.0%, 88.8%), and CER (60.7%, 74.3%). Combinations of biomarkers, such as CRP-ESR, CRP-LDH, ESR-LDH, ESR-CER, and LDH-CER, showed promising diagnostic potential, with larger area under the curve (AUC) values for IPA diagnosis in COPD patients. However, no statistically significant difference was observed between the diagnostic efficacy of single biomarkers and combined biomarkers. Notably, compared to those in the unassisted ventilation group, the patients in the assisted ventilation group (including noninvasive ventilation and tracheal intubation/incision-assisted ventilation group) exhibited significantly greater PCT and LDH levels, while the CER significantly decreased (p=0.021). There were no significant differences in biomarker levels between the ICU group and the non-ICU group. CRP (p<0.01), ESR (p=0.028), PCT (p<0.01), and CER (p<0.01) were positively correlated with hospitalization duration, whereas LDH was not correlated with hospitalization duration.ConclusionOur study highlights the diagnostic potential of CRP, ESR, PCT, LDH, and CER for IPA in COPD patients. CRP and LDH can also initially predict the need for assisted ventilation, while CRP can initially estimate the length of hospitalization. This study represents the first report of the potential of CER for diagnosing IPA, suggesting its significance for further research.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1294971/fullinvasive pulmonary aspergillosischronic obstructive pulmonary diseaseC-reactive proteinerythrocyte sedimentation rateprocalcitoninlactate dehydrogenase
spellingShingle Zhiwei Long
Xiaotong Li
Zhengtu Li
Jieying Hu
Ye Qiu
Shaoqiang Li
Yangqing Zhan
Feng Ye
Yan Wang
Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients
Frontiers in Cellular and Infection Microbiology
invasive pulmonary aspergillosis
chronic obstructive pulmonary disease
C-reactive protein
erythrocyte sedimentation rate
procalcitonin
lactate dehydrogenase
title Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients
title_full Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients
title_fullStr Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients
title_full_unstemmed Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients
title_short Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients
title_sort improved diagnostic markers for invasive pulmonary aspergillosis in copd patients
topic invasive pulmonary aspergillosis
chronic obstructive pulmonary disease
C-reactive protein
erythrocyte sedimentation rate
procalcitonin
lactate dehydrogenase
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1294971/full
work_keys_str_mv AT zhiweilong improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT xiaotongli improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT zhengtuli improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT jieyinghu improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT yeqiu improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT shaoqiangli improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT yangqingzhan improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT fengye improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients
AT yanwang improveddiagnosticmarkersforinvasivepulmonaryaspergillosisincopdpatients